Currently Browsing:Benson Henry Institute for Mind Body Medicine
Designed to supplement the medical treatment of cancer patients by giving them tools to cope with the stress of their illness, make informed choices about treatment, and maintain hope.
Currently Browsing:Cancer Center
The Cancer Imaging & Intervention Program at Massachusetts General Hospital Imaging combines leading-edge technology and the expertise of specialty-trained radiologists to provide comprehensive cancer detection and monitoring, plus image-guided treatments for specific types of cancer.Request an Appointment
Call to request an appointment 617-724-9729
Currently Browsing:Radiation Oncology
Specialists in the Genitourinary Program in the Department of Radiation Oncology are renowned for their expertise in using advanced radiation therapies to treat cancers of the urinary tract (men and women) and the reproductive tract (men).
Physicians in the Massachusetts General Hospital Department of Urology's Bladder, Kidney, Penile, Prostate and Testicular Cancer Program specialize in using advanced surgical therapies and minimally invasive procedures to treat male and female genitourinary cancers.
The Reconstructive Urology Service at Massachusetts General Hospital is staffed by skilled and experienced surgeons who perform total and partial reconstructions of the urinary tract.
Testicular Cancer: Your Chances for Recovery (Prognosis)
What is a prognosis?
Prognosis is the word your healthcare team may use to describe your likely outcome from cancer and cancer treatment. A prognosis is a calculated guess. It’s a question many people have when they learn they have cancer.
Making a choice
The decision to ask about your prognosis is a personal one. It’s up to you to decide how much you want to know. Some people find it easier to cope and plan ahead when they know their prognosis and the statistics for how well a treatment might work. Other people find statistics confusing and frightening. Or they might think statistics are too general to be useful.
A doctor who is most familiar with your health is in the best position to discuss your prognosis with you and explain what the statistics may mean in your case. At the same time, you should keep in mind that your prognosis can change. Cancer and cancer treatment outcomes are hard to predict. For instance, a favorable prognosis (which means you’re likely going to do well) can change if the cancer spreads to key organs or doesn’t respond to treatment. An unfavorable prognosis can change, too. This can happen if treatment shrinks and controls the cancer so it doesn’t grow or spread.
What goes into a prognosis
When figuring out your prognosis, your doctor will consider all the things that could affect the cancer and its treatment. Your doctor will look at risk estimates about the exact type and stage of the cancer you have. These estimates are based on what results researchers have seen over many years in other people with the same type and stage of cancer.
If your cancer is likely to respond well to treatment, your doctor will say you have a favorable prognosis. This means you’re expected to live many years and may even be cured. If your cancer is likely to be hard to control, your prognosis may be less favorable. The cancer may shorten your life. It’s important to keep in mind that a prognosis states what’s likely or probable. It is not a prediction of what will definitely happen. No doctor can be fully certain about an outcome.
Your prognosis depends mainly on:
The exact type of cancer
The stage of the cancer
Your overall health
Your treatment decisions
How well your cancer responds to treatment
Understanding survival rates
Survival rates show what portion of people live for a certain length of time after being told they have cancer. The rates are grouped for people with certain types and stages of cancer. Many times, the numbers used refer to the 5-year or the 10-year survival rate. That’s how many people are living 5 years or 10 years after diagnosis. The survival rate includes:
People who are cancer-free
People who are still getting treatment for their cancer
What are the survival rates for testicular cancer?
Here are the 5-year survival rates for testicular cancer, according to the National Cancer Institute. These include all types of testicular cancer. The outlook for some types might be better than others.
Overall, the 5-year survival rate for testicular cancer is about 95%.
For men whose cancer is found before it has spread to lymph nodes or other organs, the 5-year survival rate is about 99%.
The 5-year survival rate for testicular cancer that has reached nearby organs or lymph nodes is about 96%.
Once testicular cancer has spread to distant organs, the 5-year survival rate is about 74%.
These numbers are adjusted to account for the fact that some people with testicular cancer may die from other causes.
Talk with your healthcare provider
You can ask your healthcare provider about survival rates and what you might expect. But remember that statistics are based on large groups of people. They cannot be used to say what will happen to you. No two people are exactly alike. Treatment and how well cancer responds to treatment vary.
Treatment and Screening in Cryptorchidism - 1/1/2016, Mass General
Although cryptorchidism is the most common congenital abnormality of the genitourinary tract, lingering uncertainties remain regarding the appropriate management and long-term consequences of an undescended testicle (UDT).
MGH and CBS care - 2/4/2011, Mass General
MGH Hotline 02.04.11 To promote awareness about the disease and the importance of self-exams, the MGH and CBS Cares are collaborating on a fun, informative public service announcement (PSA).
The Maxwell V. Blum Cancer Resource Center is a program that offers a range of support resources around the Cancer Center. The center has an ongoing mission to make support services, as well as respite and community-building areas, more accessible to patients and families throughout the Cancer Center.
The Marjorie E. Korff PACT program at the Massachusetts General Hospital Cancer Center provides psycho-educational support for parents who are patients.